top of page

Best practices for AEs on social media

4 tips for reporting AEs from Twitter and other platforms


Eventually, it will happen. If you’re following HCPs on social media, you will eventually find an AE. 


Here’s an example from Twitter:



So what should you do? How do you respond? What are your regulatory and other responsibilities?


Read on for answers…


First, let’s review what is reportable per FDA guidelines. Before reporting to the FDA, you’ll need these details:

  1. Patient: sufficient information to believe a patient had an adverse event

  2. Reporter: contact information to follow up with the reporter

  3. Medication: a biological or pharmaceutical product

  4. Adverse event: an AE or death suspected due to the product

If you’re a biotech or pharma employee, you must report within 24 hours.


If the AE was serious and unexpected, your organization must file with the FDA within 15 days. Other AEs may be reported quarterly or annually, depending on your product’s time on market. 

How the FDA regards AE reports from social media


Per FDA guidance, AE reports from social media should be treated as spontaneous reports. Spontaneous reports are unsolicited communications that mention AEs. The FDA uses the same review process for spontaneous and other reports.

Challenges with reporting AEs from social media


With 500 million posts every day on Twitter alone, the volume of social media can complicate this process. However, a closer look shows a low number of reportable AEs:

"Twitter is surprisingly clean from a pharmacovigilance perspective because HCPs know what they should and shouldn't say publicly." Jason Howard, medical digital lead at Sanofi

Complications also include incomplete reports and potential duplicates:

  • Incomplete reports. Many social media posts do not sufficiently describe the patient’s symptoms to confirm a diagnosis or condition.

  • Potential duplicates. If an AE is serious enough to justify a post, it’s likely the patient’s provider has already reported to the FDA.

How you should handle AEs on social media


To report AEs from social media, here are four recommendations:


1. Share with your PV team

Send a screenshot and a link to your PV team. Include specifics on the patient, reporter, medication and AE.


2. Use current PV processes

Leverage your audit, reconciliation and training processes. This provides consistency across channels and alignment with regulatory requirements.


3. Allow PV to respond if appropriate

Enable your PV team to reply to the original post with options to continue the conversation via private channels. This lets you collect details and answer questions while respecting privacy.


4. Include your Compliance team

As with any new process, be sure to ask for guidance from Compliance so they can support your initiatives.


For more tips, check out this infographic (click to view):



bottom of page